drugset / Trial / NCT02291094

Effect of Intravenous Infusion of Lidocaine and Remifentanil Perioperatively in Patients Undergoing Mastectomy

NCT02291094 ↗

Phase 4 Completed 60 enrolled Hospital de Base
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study aims to compare quality of perioperative analgesia of lidocaine and remifentanil intravenously in surgical interventions for the treatment of breast cancer.

Timeline

Start
2013-08
Primary completion
2014-08
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 3 mg/kg Intravenous
Comparator Remifentanil Small molecule 0.1 ug/kg Intravenous

Indications

No indication recorded.